United States · Bill · S
S. 974 (115th)
CREATES Act of 2018
Introduced
27 April 2017
Last action
—
Status
Placed on Senate Legislative Calendar under General Orders. Calendar No. 482.
Sponsors
—
Subjects
Discovery layer
Source updated
10 August 2026
Summary
Creating and Restoring Equal Access To Equivalent Samples Act of 2017 or the CREATES Act of 2017 This bill permits the developer of a drug or biological product to bring a civil action against the license holder of an approved drug or biological product if the holder has declined to make available sufficient quantities of the approved drug or product for the developer's testing.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
5 official files
Reported to Senate (text)
Reported to Senate · EN · 21 June 2018
Reported to Senate (PDF)
Reported to Senate · EN · 21 June 2018
Introduced in Senate (text)
Introduced in Senate · EN · 27 April 2017
Introduced in Senate (PDF)
Introduced in Senate · EN · 27 April 2017
Introduced in Senate
summary · EN · 27 April 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/senate-bill/974
- Open data entity: https://api.congress.gov/v3/bill/115/s/974